BioAge Labs, Inc (BIOA) — Financial Flexibility Index
BioAge Labs, Inc (BIOA) has a Financial Flexibility Index of -0.86x as of June 2026. Free cash flow of $-18.93 Million (operating CF $-19.26 Million minus capex $328.00K) represents -1% of total liabilities ($22.02 Million). Check tangible net worth ratio of BioAge Labs, Inc to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioAge Labs, Inc Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for BioAge Labs, Inc across 9 annual periods. For the full cash flow conversion analysis, see BIOA cash flow metrics.
Annual Financial Flexibility Index for BioAge Labs, Inc (2013–2025)
Year-by-year free cash flow to debt coverage for BioAge Labs, Inc. Explore debt repayment capacity of BioAge Labs, Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.54x | $-80.91 Million | $-81.63 Million | $22.84 Million | ▼ -143.1% |
| 2024 | -1.46x | $-51.16 Million | $-51.52 Million | $35.11 Million | ▼ -680.8% |
| 2023 | -0.19x | $-37.20 Million | $-37.36 Million | $199.32 Million | ▲ +27.1% |
| 2022 | -0.26x | $-36.08 Million | $-36.18 Million | $140.99 Million | ▲ +59.1% |
| 2017 | -0.63x | $-29.79 Million | $-29.79 Million | $47.66 Million | ▼ -87.5% |
| 2016 | -0.33x | $-37.62 Million | $-37.62 Million | $112.84 Million | ▼ -0.1% |
| 2015 | -0.33x | $-32.20 Million | $-32.20 Million | $96.73 Million | ▼ -40.7% |
| 2014 | -0.24x | $-22.45 Million | $-22.45 Million | $94.91 Million | ▲ +21.2% |
| 2013 | -0.30x | $-14.74 Million | $-27.52 Million | $49.07 Million | — |